Kneading technique for preparation of binary solid dispersion of meloxicam with poloxamer 188

AAPS PharmSciTech

Volumn 10, Issue 4, 2009, Pages 1206-1215

  Ghareeb, Mowafaq M ^a   Abdulrasool, Alaa A ^a   Hussein, Ahmed A ^a   Noordin, Mohammed I ^b  

^a UNIVERSITY OF BAGHDAD   (Iraq)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Factorial design; Kneading; Poloxamer; Poorly water soluble drug; Solid dispersion

Indexed keywords

MELOXICAM; POLOXAMER; POLYMER;

ARTICLE; CONTACT ANGLE; CONTROLLED STUDY; DATA ANALYSIS; DEPENDENT VARIABLE; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSION; DISPERSION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; FACTORIAL DESIGN; INDEPENDENT VARIABLE; INFRARED SPECTROSCOPY; MULTIPLE LINEAR REGRESSION ANALYSIS; SCANNING ELECTRON MICROSCOPY; STATISTICAL MODEL; TIME; X RAY DIFFRACTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALORIMETRY, DIFFERENTIAL SCANNING; MICROSCOPY, ELECTRON, SCANNING; POLOXAMER; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TECHNOLOGY, PHARMACEUTICAL; THIAZINES; THIAZOLES; X-RAY DIFFRACTION;

EID: 75549090079     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-009-9316-0     Document Type: Article

References (25)

1. M Pairet J van Ryn H Schierok A Mauz G Trummlitz G Engelhardt 1998 Differential inhibition of cyclooxygenases-1 and -2 by meloxicam and its 40-isomer Inflamm Res 47 6 270 6 10.1007/s000110050329 1:CAS:528: DyaK1cXktVejsbc%3D 9683035 (Pubitemid 28325586)
2. P Lugar K Daneck W Engel G Trummlitz K Wagner 1996 Structure and physicochemical properties of meloxicam, a new NSAID Eur J Pharm Sci 4 175 87 10.1016/0928-0987(95)00046-1 (Pubitemid 26174671)
3. GR Lipscomb N Wallis G Armstrong WD Rees 1998 Gastrointestinal tolerability of meloxicam and piroxicam: a double-blind placebo-controlled study Br J Clin Pharmacol 46 2 133 7 10.1046/j.1365-2125.1998.00761.x 1:CAS:528:DyaK1cXlsFCit7k%3D 9723821 (Pubitemid 28342783)
4. D Türck W Roth U Busch 1996 A review of the clinical pharmacokinetics of meloxicam Br J Rheumatol 35 Suppl 1 13 6 8630630
5. NB Naidu KP Chowdary KV Murthy V Satyanarayana AR Hayman G Becket 2004 Physicochemical characterization and dissolution properties of meloxicam-cyclodextrin binary systems J Pharm Biomed Anal 35 1 75 86 10.1016/j.jpba.2004.01.003 1:CAS:528:DC%2BD2cXitFeis74%3D 15030882 (Pubitemid 38368862)
6. SG Vijaya Kumar DN Mishra 2006 Preparation and evaluation of solid dispersion of meloxicam with skimmed milk Yakugaku Zasshi 126 2 93 7 10.1248/yakushi.126.93 16462098
7. SG Vijaya Kumar DN Mishra 2006 Preparation, characterization and in vitro dissolution of solid dispersion of meloxicam with PEG6000 Yakugaku Zasshi 126 8 657 64 10.1248/yakushi.126.657 16880724 (Pubitemid 44180773)
8. Collett JH, Popli H, Kibbe AH, editors. Poloxamer. In: Handbook of Pharmaceutical Excipients, 3rd ed. London, UK: Pharmaceutical Press; 2000. p. 386-8.
9. Y Hang C Myung-Kwan C Hoo-Kyun 2007 Preparation and characterization of piroxicam/poloxamer solid dispersion prepared by melting method and solvent method J Korean Pharm Sci 37 1 5
10. S Chutimaworapan GC Ritthidej E Yonemochi T Oguchi K Yamamoto 2000 Effect of water-soluble carriers on dissolution characteristics of nifedipine solid dispersions Drug Dev Ind Pharm 26 11 1141 50 10.1081/DDC-100100985 1:CAS:528:DC%2BD3cXnvVSntbY%3D 11068687 (Pubitemid 30807499)
11. A Modi P Tayade 2006 Enhancement of dissolution profile by solid dispersion (kneading) technique AAPS PharmSciTech 7 3 68 10.1208/pt070368 17025249 (Pubitemid 44309025)
12. AS Elkheshen NA Abdel-Gawad AA Badawi 1997 Factorial design and computer optimisation of a reconstitutable suspension of erythromycin ethyl succinate Die Pharm Ind 59 5 439 43 1:CAS:528:DyaK2sXjvVequ7Y%3D
13. Higuchi T, Connors KA. "Phase-solubility techniques" in advances in analytical chemistry and instrumentation. New York: Reilly CN; 1965. p. 117-212.
14. Bolton S, Charles S. Pharmaceutical statistics. New York, NY: Marcel Dekker Inc.; 2004.
15. WL Chiou S Riegelman 1971 Pharmaceutical applications of solid dispersion systems J Pharm Sci 60 1281 302 10.1002/jps.2600600902 1:STN:280: DyaE3M3otFersQ%3D%3D 4935981
16. B Singh T Kaur S Singh 1997 Correction of raw dissolution data for loss of drug and volume during sampling Indian J Pharm Sci 59 196 9 1:CAS:528:DyaK2sXmslOqu7w%3D
17. KA Khan 1975 The concept of dissolution efficiency J Pharm Pharmacol 27 48 9 1:CAS:528:DyaE2MXhsVCru7o%3D 235616
18. MC Gohel MK Panchal 2002 Novel use of similarity factor f2 and Sd for the development of diltiazem HCl modified-release tablets using a 32 factorial design Drug Dev Ind Pharm 28 77 87 10.1081/DDC-120001488 1:CAS:528: DC%2BD38Xht1Omtro%3D 11858527 (Pubitemid 34274562)
19. A McKenna DF McCafferty 1982 Effect of particle size on the compaction mechanism and tensile strength of tablets J Pharm Pharmacol 34 6 347 51 1:STN:280:DyaL383ktFGmsA%3D%3D 6124615
20. T Imai T Nishiyama M Ueno M Otagiri 1989 Enhancement of the dissolution rates of poorly water-soluble drugs by water-soluble gelatin Chem Pharm Bull 37 8 2251 2 1:CAS:528:DyaL1MXlvVSmur8%3D 2598331
21. HA Merchant HM Shoaib J Tazeen RI Yousuf 2006 Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: a technical note AAPS PharmSciTech 7 3 78 10.1208/pt070378 17025258 (Pubitemid 44548845)
22. M Cirri P Mura AM Rabasco, et al. 2004 Characterization of ibuproxam binary and ternary dispersions with hydrophilic carriers Drug Dev Ind Pharm 30 1 65 74 10.1081/DDC-120027513 1:CAS:528:DC%2BD2cXpt1Sgug%3D%3D 15000431 (Pubitemid 38240477)
23. RC Mashru VB Sutariya MG Sankalia JM Sankalia PP Parikh 2005 Development and evaluation of fast dissolving film of salbutamol sulphate Drug Dev Ind Pharm 31 25 34 1:CAS:528:DC%2BD2MXhtlaqtL4%3D 15704855
24. AA Ambike KR Mahadik A Paradkar 2004 Stability study of amorphous valdecoxib Int J Pharm 282 151 62 10.1016/j.ijpharm.2004.06.009 1:CAS:528:DC%2BD2cXntVGhsLg%3D 15336390 (Pubitemid 39178492)
25. MY Heo ZZ Piao TW Kim QR Cao A Kim BJ Lee 2005 Effect of solubilizing and microemulsifying excipients in polyethylene glycol 6000 solid dispersion on enhanced dissolution and bioavailability of ketoconazole Arch Pharm Res 28 5 604 11 10.1007/BF02977766 1:CAS:528:DC%2BD2MXltVamtbw%3D 15974450